The Street’s Key Stock Analysts Research Reports

$XEC, $COST, $ENDP, $FCX, $HD, $LOW Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid. Below is a list of stocks analysts have singled out to look at carefully Friday, as follows: Cimarex Energy Co. (NYSE:XEC) was downgraded to Market […]

The Street’s Key Stock Analysts Research Reports

$AMAG, $AVTR, $DLTR, $ENDP, $FB, $NBEV Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid. Below is a list of The Street’s Key analysts outlook for Key issues for Wednesday follows: AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) was started as Overweight with […]

The Street’s Key Stock Analysts Research Reports

$AGN, $BDSI, $CREE, $DLTR, $LLY, $ENDP, $BTU Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid. Below is a list of The Street’s Key analysts outlook for Key issues for Thursday as follows: Allergan PLC (NYSE:AGN) was started with a […]

Medical Grade Marijuana, The Solution to America’s Opioid Addiction?

Medical Grade Marijuana, The Solution to America’s Opioid Addiction?

Medical Grade Marijuana, The Solution to America’s Opioid Addiction? $ENDP Last Thursday, the FDA took an unprecedented step in an attempt to curb America’s opioid abuse crisis, but that does not yet mean that medical grade marijuana will be more seriously considered as an alternative to the highly addictive and deadly heroin like Rx drugs. […]

FDA Asked a Drug-maker to Remove Opioid Painkiller from Market

FDA Asked a Drug-maker to Remove Opioid Painkiller from Market

FDA Asked a Drug-maker to Remove Opioid Painkiller from Market $ENDP US regulators want a narcotic painkiller involved in the opioid epidemic off the market amid data showing people continue to abuse it. The US Food and Drug Administration has asked Endo Pharmaceuticals (NASDAQ:ENDP) to stop selling its reformulated, extended-release painkiller, Opana ER, after concluding […]